Radiation Oncology Sarcoma INTERCEPTION Biobanking Study

Overview

About this study

The purpose of this study is to collect and analyze specimens that will correlate with clinical outcomes such as acute and late toxicities, quality of life, local control, and survival of patients treated with radiation therapy for future research.  

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

  • Patients with histology proven sarcoma, including well-differentiated or dedifferentiated liposarcoma, synovial sarcoma or malignant peripheral nerve sheath tumor (MPNST) with plan for radiation therapy and surgical resection or spatially fractionated radiation therapy (SFRT) 

  • Age: 14 years or older 

 

Exclusion Criteria:

  • Patients unwilling or unable to provide consent to enroll in the study.

  • Patients with current metastatic disease if their treatment plan includes definitive preoperative radiation therapy and surgical resection

Note: Other protocol defined Inclusion/Exclusion Criteria may apply.

Eligibility last updated 07/27/2026. Questions regarding updates should be directed to the study team contact.

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status Contact

Rochester, Minn.

Mayo Clinic principal investigator

Katie Lee, M.D., Ph.D.

Open for enrollment

Contact information:

Cancer Center Clinical Trials Referral Office

(855) 776-0015

More information

Publications

Publications are currently not available
.
CLS-20611132

Mayo Clinic Footer